METASTATIC BLADDER UROTHELIAL CARCINOMA
Clinical trials for METASTATIC BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo aims to shrink bladder tumors before surgery
Disease control Recruiting nowThis study tests whether giving a targeted drug (enfortumab vedotin) plus an immunotherapy (pembrolizumab) before surgery to remove part or all of the bladder can improve outcomes for people with advanced bladder or upper urinary tract cancer. About 75 adults with cancer that has…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 04:24 UTC
-
Blood filtering may reboot bladder cancer treatment
Disease control Recruiting nowThis study tests a new approach for people with advanced bladder or urinary tract cancer that has stopped responding to standard treatments. Researchers want to see if filtering the blood (plasma exchange) before giving two approved cancer drugs can help the drugs work better. Ab…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
Targeted drug trial hopes to shrink tumors in patients with specific gene mutations
Disease control Recruiting nowThis study tests the drug pemetrexed in people with metastatic bladder cancer or other solid tumors that have certain gene mutations (MLL4, UTX, or MTAP). The drug works by blocking a nutrient cancer cells need to grow. Researchers want to see if it can shrink tumors in these pat…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New platform aims to predict which cancer treatments will work
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 participant…
Matched conditions: METASTATIC BLADDER UROTHELIAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 04:12 UTC